| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/11/2003 | WO2003102016A2 Amyloid peptide inactivating enzyme to treat alzheimer's disease |
| 12/11/2003 | WO2003102001A1 Polyol-modified silanes as precursors for silica |
| 12/11/2003 | WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 12/11/2003 | WO2003101611A1 Isolation material for hormone disrupting substance, method of concentrating and method of clean-up |
| 12/11/2003 | WO2003101586A1 Cell recovery |
| 12/11/2003 | WO2003101580A1 Solid mycoctoxin carriers |
| 12/11/2003 | WO2003101497A1 Knockout mice and their use |
| 12/11/2003 | WO2003101489A1 Medicinal composition for treatment for digestive tract disease |
| 12/11/2003 | WO2003101487A1 Use of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease |
| 12/11/2003 | WO2003101486A2 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
| 12/11/2003 | WO2003101481A1 Treatment of neurodegenerative diseases using proteasome modulators |
| 12/11/2003 | WO2003101459A1 Antagonizing nk1 receptors inhibits consumption of substances of abuse |
| 12/11/2003 | WO2003101416A1 Selective removal of contaminants from a surface using colored magnetic particles and articles having magnets |
| 12/11/2003 | WO2003101401A2 Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer |
| 12/11/2003 | WO2003101400A2 Cancer-linked gene as target for chemotherapy |
| 12/11/2003 | WO2003101394A2 Defensins: use as antiviral agents |
| 12/11/2003 | WO2003101392A2 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 12/11/2003 | WO2003101388A2 Human solute carrier family 7 member 11 (hslc7a11) |
| 12/11/2003 | WO2003101386A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 12/11/2003 | WO2003101304A1 Embedded piezoelectric microcantilever sensors |
| 12/11/2003 | WO2003101284A2 Methods of diagnosing and treating diabetes and insulin resistance |
| 12/11/2003 | WO2003101278A2 Device and method of use for detection and characterization of pathogens and biological materials |
| 12/11/2003 | WO2003101188A1 Chronic stress-related disease model animal and method of constructing the same |
| 12/11/2003 | WO2003101187A1 Animal model for toxicology and dose prediction |
| 12/11/2003 | WO2003101176A2 Method, composition and kit for antigenic binding of norwalk-like viruses |
| 12/11/2003 | WO2003093791A3 Fast electrical lysis of cells and rapid collection of the contents thereof using capillary electrophoresis |
| 12/11/2003 | WO2003091667A3 Method for recording the boiling-point curve of liquids and device for carrying out said method |
| 12/11/2003 | WO2003087993A9 Oligonucleotide probes for genosensor chips |
| 12/11/2003 | WO2003080823A3 Bacteriophages useful for therapy and prophylaxis of bacterial infections |
| 12/11/2003 | WO2003078975A3 Wiper and brush device for cleaning water quality sensors |
| 12/11/2003 | WO2003076940A3 Acyl fluoride activation of carboxysilyl-coated glass substrates |
| 12/11/2003 | WO2003075007A3 Methods for absolute cell counting |
| 12/11/2003 | WO2003073068A3 Population based assessments and means to rank the relative immunogenicity of proteins |
| 12/11/2003 | WO2003070265A3 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis |
| 12/11/2003 | WO2003066885A3 Method for screening for compounds having hdac inhibitory activity |
| 12/11/2003 | WO2003066128A3 Autonomous, ambulatory analyte monitor or drug delivery device |
| 12/11/2003 | WO2003066079A3 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds |
| 12/11/2003 | WO2003064624A3 Molecular hepatotoxicology modeling |
| 12/11/2003 | WO2003064463A3 Pluripotency determining factors and uses thereof |
| 12/11/2003 | WO2003062462A3 Method for isolating nucleic acids and protein from a single sample |
| 12/11/2003 | WO2003060465A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis |
| 12/11/2003 | WO2003059877A3 Novel affinity labels |
| 12/11/2003 | WO2003056296A3 Improved methods for determining binding affinities |
| 12/11/2003 | WO2003054792A3 System and methods for measuring at least one metabolic rate of a plurality of cells |
| 12/11/2003 | WO2003054515A3 Fabrication of surfaces with reduced protein adsorption and/or cell adhesion |
| 12/11/2003 | WO2003053857A9 Forming and modifying dielctrically-engineered microparticles |
| 12/11/2003 | WO2003052110A3 Nucleic acid nematicides |
| 12/11/2003 | WO2003051834A3 Immunocellular receptors related to neurological disorders |
| 12/11/2003 | WO2003051180A3 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 12/11/2003 | WO2003050542A3 Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assaykit |
| 12/11/2003 | WO2003050296A3 Method for determining the activity of ornithine decarboxylase and for identifying effectors of ornithine decarboxylase activity |
| 12/11/2003 | WO2003042688A3 Method for determining hydraulic permeability of a material |
| 12/11/2003 | WO2003040385A3 Membrane protein interaction assays |
| 12/11/2003 | WO2003040288A3 Isotopically coded affinity markers 3 |
| 12/11/2003 | WO2003038121A3 Method for the detection of cytosine methylation in immobilised dna samples |
| 12/11/2003 | WO2003038037A3 Glycogen synthase kinase function in endothelial cells |
| 12/11/2003 | WO2003038033A3 Protein and peptide nanoarrays |
| 12/11/2003 | WO2003037172A9 Endothelial-cell binding peptides for diagnosis and therapy |
| 12/11/2003 | WO2003034996A3 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 12/11/2003 | WO2003033672A3 Nr3b nmda receptor subunit compositions and related methods |
| 12/11/2003 | WO2003033663A8 Rankl mimics and uses thereof |
| 12/11/2003 | WO2003031983A3 Method for detecting amino acids |
| 12/11/2003 | WO2003031936A3 System, method, and apparatus for submitting genetic samples and receiving genetic testing results anonymously |
| 12/11/2003 | WO2003030622A3 Detection and characterization of pyschoactives using analysis of network level physiological responses in a neuronal sample |
| 12/11/2003 | WO2003029825A3 Method for predicting the sensitivity to chemotherapy |
| 12/11/2003 | WO2003029422A3 Noonan syndrome gene |
| 12/11/2003 | WO2003029415A3 Methods for determining oligosaccharide binding |
| 12/11/2003 | WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 12/11/2003 | WO2003029292A3 Gene regulatory peptides |
| 12/11/2003 | WO2003027326A3 Nucleic acid sequencing by raman monitoring of molecular deconstruction |
| 12/11/2003 | WO2003025220A3 Fusion proteins useful for detecting analytes |
| 12/11/2003 | WO2003025218A3 Methods and yeast strains for screening antifungal agents |
| 12/11/2003 | WO2003025012A3 Therapeutic vaccine peptide complex for preventing and treating disorders in mammals |
| 12/11/2003 | WO2003024306A3 Early diagnosis of stroke |
| 12/11/2003 | WO2003020902A3 Methods for blocking nonspecific hybridizations of nucleic acid sequences |
| 12/11/2003 | WO2003019184A9 Biometric quality control process |
| 12/11/2003 | WO2003019147A3 Enzyme-amplified redox microarray detection process |
| 12/11/2003 | WO2003016484A3 Gleason grade 4/5 prostate cancer genes |
| 12/11/2003 | WO2003012451A3 Methods for detecting of intermoleculair interactions using protein arrays |
| 12/11/2003 | WO2003012390A3 Methods and devices for detecting hydrocarbons and petroleum products |
| 12/11/2003 | WO2003010556A3 Real-time digital x-ray imaging apparatus |
| 12/11/2003 | WO2003008968A3 Human tissue specific drug screening procedure |
| 12/11/2003 | WO2003002750A3 High throughput assay system |
| 12/11/2003 | WO2003002748A3 Detection of microbiological contaminants in samples of non-living material |
| 12/11/2003 | WO2003002730A3 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 12/11/2003 | WO2003000727A3 Atopy |
| 12/11/2003 | WO2002101086A3 Complete mitochondrial genome sequences as a diagnostic tool for the health sciences |
| 12/11/2003 | WO2002099391A3 Particle probe |
| 12/11/2003 | WO2002099383A8 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays |
| 12/11/2003 | WO2002094009A3 Methods for selecting and producing animals having a predicted level of immune response |
| 12/11/2003 | WO2002089567A3 Sca2 knockout animal and methods of use |
| 12/11/2003 | WO2002086667A3 Computer software for automated annotation of biological sequences |
| 12/11/2003 | WO2002086448B1 Detection of microsatellite instability and its use in diagnosis of tumors |
| 12/11/2003 | WO2002083841A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/11/2003 | WO2002076608A3 Method for producing an array for detecting constituents from a biological sample |
| 12/11/2003 | WO2002075507B1 Anti-bacterial vaccine compositions |
| 12/11/2003 | WO2002075274A3 Method and kit for following neurodegenerative diseases |
| 12/11/2003 | WO2002072013A3 Method of treating malignancies through induction of blood immune responses |
| 12/11/2003 | WO2002070731A3 Methods and primers for evaluating hiv-1 mutations |
| 12/11/2003 | WO2002065943A3 Ocular tear growth factor-like protein |